A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars-Reference-Cited by-同舟云学术

A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars

Published:2024-02-15 Issue:8 Volume:18 Page:6162-6175
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Nagpal Shakti¹^ORCID,Png Yi Jie Jordan¹,Malinovskaya Julia²,Kovshova Tatyana²,Jain Pankaj³⁴,Naik Sachin³⁴,Khopade Ajay³⁴,Bhowmick Subhas³⁴,Shahi Pradeep³⁴,Chakra Amaresh³⁴,Bhokari Ashutosh³⁴,Shah Vishal³⁴,Gelperina Svetlana²,Wacker Matthias G.¹^ORCID

Affiliation:

1. Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, 4 Science Drive 2, Singapore 117544, Singapore

2. Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, Moscow 125047, Russia

3. Sun Pharma Advanced Research Company Ltd., 17 B Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra 400093, India

4. Sun Pharma Advanced Research Centre (SPARC), Tandalja, Vadodara, Gujarat 390 020, India

Funder

Ministry of Education - Singapore

Sun Pharma

Faculty of Science, National University of Singapore

Ministry of Science and Higher Education of the Russian Federation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c08290